welcomes you to the new, improved website!
Nicolas Girard
Video
Since the publication of the results of the CheckMate 816 trial (1), neoadjuvant chemoimmunotherapy has been introduced as a standard of care for stage IB-IIIA resectable NSCLC without mutations. The use of minimally invasive approaches...
Article
This is the twelfth session of the 4th International Conference for Sublobar Resections and Evolving Techniques for Lung Cancer, held in January 2023. It includes talks from seven global experts...
Video
As a part of Session 12 of the 4th International Conference for Sublobar Resections and Evolving Techniques for Lung Cancer, Nicolas Girard of Paris, France, presented on the possibility of...